9:00 a.m.
Opening speech 🎤
9:10 – 9:30 a.m.
Vaccination, longevity and public health – Prof. Patrick Berche
9:30 – 9:50 a.m.
Obépine project and wastewater surveillance – Prof. Vincent Maréchal
9:50 – 10:10 a.m.
State of the art of cardiovascular risk prevention – Prof. Gabriel Laurent
Cofee Break☕
10:30 – 10:50 a.m.
Modern prevention and longevity: an unprecedented alignment of stars – Prof. Fabrice Denis
10:50 – 11:10 a.m.
Genomics and prevention: toward democratization?– Prof. F. Denis
11:10 – 11:30 a.m.
Photobiomodulation for brain treatment: state of the art and perspectives– G. Blivet
11:30 a.m. – 12:10 p.m.
1st Round TableGenomics, Epigenomics and Clinical Practice: Current synergies and perspectives for the preventive medicine of tomorrow
12:10 -12:40 p.m.
Industry Session
Lunch break, networking 🍽️
2:00 – 2:20 p.m.
The AXIA Medicine project: what preventive and longevity medicine in the United States? – Dr Alessandro Riccombeni
2:20 – 2:40 p.m.
Medico-economic challenges of preventive and longevity medicine: a prospective analysis in light of strategic health policy directions – Prof. Jean-Jacques Zambrowski
2:40 – 3:00 p.m.
Regulatory environment in France and Europe for the practice of preventive and genomic medicine – Valérie Sarazin
3:20 – 3:40 p.m.
National strategy for accelerating prevention – Dr Florie Fillol
3:40 – 4:00 p.m.
How can data models useful for preventive medicine be built within an ethical and secure framework? – Dr. Philippe Jean Bousquet
4:00 – 4:20 p.m.
Which digital solutions and what pathway are needed to enable the deployment of preventive services for all? – Benoît Bresson
4:20 – 5:00 p.m.
2nd Round TableWhat industrial ecosystem for the development of preventive and longevity medicine?
17:00 p.m.
Closing speech 🎤
